(Q37165366)

18 August 2017

1 reference

title

Vaccination with cytokines in autoimmune diseases (English)

1 reference

18 August 2017

5

Jean-François Zagury

1 reference

18 August 2017

Laure Delavallée

1

1 reference

18 August 2017

Eric Assier

2

1 reference

18 August 2017

Anne Denys

3

1 reference

18 August 2017

Géraldine Falgarone

4

1 reference

18 August 2017

Sylvianne Muller

6

1 reference

18 August 2017

Natacha Bessis

7

1 reference

18 August 2017

Marie-Christophe Boissier

8

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

40

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

343-351

1 reference

The role of the innate immune response in autoimmune disease

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Cytokines and anti-cytokine biologicals in autoimmunity: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Autoimmune aspects of cytokine and anticytokine therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Gene therapy for patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Therapeutic vaccination for chronic diseases: a new class of drugs in sight

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

TNF-blocking therapies: an alternative mode of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Immunological therapies for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Antigen epitope-expressing cytokines for DNA immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

A virus-like particle-based vaccine selectively targeting soluble TNF-alpha protects from arthritis without inducing reactivation of latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Active immunization against murine TNFalpha peptides in mice: generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

IL-17 in rheumatoid arthritis: a new target for treatment or just another cytokine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Therapeutic Dosing with Anti-Interleukin-13 Monoclonal Antibody Inhibits Asthma Progression in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

A second vaccine revolution for the new epidemics of the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890801995298

10.1080/07853890801995298

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference